The Top 10 Things You Need to Know About ADNCA Datasets Guide The Top 10 Things You Need to Know About ADNCA Datasets Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…CertaraSeptember 11, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Danielle PillsburyAugust 29, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025
Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Blog Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…CertaraAugust 6, 2025
Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches Webinar Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches CertaraAugust 1, 2025
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development Case Study Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.CertaraJuly 29, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.CertaraJuly 29, 2025